Skip to main content
# Title Research Member Research Year
101 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. Prof. Mohamed Ibrahim Mohamed El-Sayed 2016
102 Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy Dr. Yasser Gaber Ali Abdelhafez 2016
103 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Prof. Mohamed Ibrahim Mohamed El-Sayed 2015
104 The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma Dr. Yasser Gaber Ali Abdelhafez 2015
105 Influence of patient and breast setup errors on dose distribution of tangential IMRT (t-IMRT) and VMAT deliveries in breast cancer: a search for optimal IGRT matching strategy for patients with average or large breast sizes Dr. Moamen Mohamed Omran Moustafa Aly 2015
106 Intravenous Fluorouracil versus Oral Capecitabine: Postoperative Chemoradiation for Gastric Cancer Dr. Shaimaa / Elsayyed Youssef / Ahmed 2015
107 Laparoscopy assisted distal gastrectomy for T1 to T2 stage gastric cancer: a pilot study of three ports technique Prof. Hamza Abbas Hamza Mohammed 2015
108 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Prof. Mohamed Ibrahim Mohamed El-Sayed 2015
109 The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma Dr. Yasser Gaber Ali Abdelhafez 2015
110 Vergleich der Biologisch Effektiven Dosen bei der Brustbestrahlung mittels Simultan Integriertem und Sequentiellem Boost Dr. Moamen Mohamed Omran Moustafa Aly 2015